Zymeworks (ZYME) reported a sharp swing into profitability following a large milestone payment from Jazz Pharmaceuticals tied to FDA approval of Ziihera, and management raised full year 2026 revenue ...
Source LinkZymeworks (ZYME) reported a sharp swing into profitability following a large milestone payment from Jazz Pharmaceuticals tied to FDA approval of Ziihera, and management raised full year 2026 revenue ...
Source Link
Comments